Provided are methods and compositions for selectively targeting CRKL through the use of targeting peptides. Selective targeting of secreted CRKL through the use of a targeting peptide may be used, for example, in the treatment of cancer to deliver a chemotherapeutic compound, fusion protein, or fusion construct to a cancer cell or tissue.
申请公布号
WO2009155556(A3)
申请公布日期
2010.04.08
申请号
WO2009US48024
申请日期
2009.06.19
申请人
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM;ARAP, WADIH;MINTZ, PAUL, J.;PASQUALINI, RENATA